Suppression of VLDL secretion by cultured hepatocytes incubated with chylomicron remnants enriched in n-3 polyunsaturated fatty acids is regulated by hepatic nuclear factor-4α

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1791, Issue 12, 2009, Pages 1181-1189

  López Soldado, Iliana ^a   Avella, Michael ^a   Botham, Kathleen M ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Chylomicron remnant; Hepatic nuclear factor 4 ; n 3 polyunsaturated fatty acid; Rat hepatocyte; Sterol regulatory element binding protein; Very low density lipoprotein

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; ADENOSINE TRIPHOSPHATE CITRATE LYASE; APOLIPOPROTEIN B; CHYLOMICRON REMNANT; FATTY ACID SYNTHASE; HEPATIC NUCLEAR FACTOR 4ALPHA; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; LIPID TRANSFER PROTEIN; MESSENGER RNA; NUCLEAR FACTOR; OMEGA 3 FATTY ACID; SATURATED FATTY ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; APOLIPOPROTEIN E; FISH OIL; HEPATOCYTE NUCLEAR FACTOR 4; PALM OIL; VEGETABLE OIL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FISH; GENE EXPRESSION; LIPOPROTEIN SECRETION; LIVER CELL; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CELL CULTURE; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SECRETION; WISTAR RAT;

RATTUS;

ANIMALS; APOLIPOPROTEINS E; CELLS, CULTURED; CHYLOMICRON REMNANTS; FATTY ACIDS, OMEGA-3; FISH OILS; GENE EXPRESSION REGULATION; HEPATOCYTE NUCLEAR FACTOR 4; HEPATOCYTES; LIPOPROTEINS, VLDL; MALE; PLANT OILS; RATS; RATS, WISTAR; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEINS;

EID: 73949130456     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.08.004     Document Type: Article

References (56)

1. Grundy S. Cholesterol and coronary heart disease. The 21st century. Arch. Intern. Med. 158 (1997) 1156-1158
2. Miller M. Current perspectives on the management of hypertriglyceridemia. Am. Heart J. 140 (2000) 232-240
3. Brewer B. Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increase risk of cardiovascular disease. Am. J. Cardiol. 83 9B (1999) 3F-12F
4. Grundy S.M., and Denke M.A. Dietary influences on serum lipids and lipoproteins. J. Lipid Res. 31 (1990) 1149-1172
5. Mensink R.P., and Katan M.B. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler. Thromb. 12 (1992) 911-919
6. Moreno J.J., and Mitjavila M.T. The degree of unsaturation of dietary fatty acids and the development of atherosclerosis. J. Nutr. Biochem. 14 (2003) 182-195
7. Shepherd J., Packard C.J., Grundy S.M., Yeshurn A.M., Gotto A.M., and Taunton O.D. Effects of saturated and polyunsaturated fat diets on the chemical composition and metabolism of low density lipoproteins in man. J. Lipid Res. 21 (1980) 91-99
8. Thornberg J.T., and Rudel L.L. How do polyunsaturated fatty acids lower lipids?. Curr. Opin. Lipidol. 3 (1992) 17-21
9. von Lossonczy T.O., Ruiter A., Bronsengeest-Schoute H.C., von Gent C.M., and Hermus R.J.J. The effect of a fish oil diet on serum lipids in healthy subjects. Am. J. Clin. Nutr. 31 (1978) 1340-1346
10. Philipson B.E., Rothrock D.W., Connor W.E., Harris W.S., and Illingworth D.R. Reduction of plasma lipids, lipoproteins and apoproteins by dietary fish oils in patients with hypertriglyeridemia. N. Engl. J. Med. 312 (1985) 1210-1216
11. Davidson M.H. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am. J. Cardiol. 98 suppl (2006) 27i-33i
12. Roche H.M., and Gibney M.J. Effect of long chainn-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism. Am. J. Clin. Nutr. 71 (2002) 232S-237S
13. Redgrave T.G. Formation and metabolism of chylomicrons. Int. Rev. Physiol. 28 (1983) 103-130
14. Nguyen P., Leray V., Diez M., Serisier S., Le Bloch J., Siliart B., and Dumon H. Liver lipid Metabolism. J. Anim. Physiol. Anim. Nutr. (Berl.) 92 (2008) 272-283
15. Gibbons G.F., Wiggins D., Brown A.-M., and Hebbachi A.M. Synthesis and function of hepatic very-low-density lipoprotein. Biochem. Soc. Trans. 32 (2004) 59-64
16. Hussain M.M., Rava P., Pan X., Dai K., Dougan S.K., Iqbal J., Lazare F., and Khatun I. Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism. Curr. Opin. Lipidol. 19 (2008) 277-284
17. Harris W.S., Connor W.E., Illingworth D.R., Rothrock D.W., and Foster D.M. Effects of fish oil on VLDL triglyceride kinetics in humans. J. Lipid Res. 31 (1990) 1549-1558
18. Ribiero A., Mageney M., Cardot P., Loriette C., Rayssiguier Y., Chambaz J., and Bereziat G. Effect of dietary fish oil and corn oil on lipid metabolism and apolipoprotein gene expression by rat liver. Eur. J. Biochem. 196 (1991) 499-507
19. Brown A.-M., Baker P.W., and Gibbons G.F. Changes in fatty acid metabolism in rat hepatocytes in response to dietary n- 3 fatty acids are associated with changes in the intracellular metabolism and secretion of apolipoprotein B48. J. Lipid Res. 38 (1997) 469-481
20. Brown A.-M., Castle J., Hebbachi A.M., and Gibbons G.F. Administration of n- 3 fatty acids in the diets of rats or directly to hepatocyte cultures results in different effects on hepatocellular ApoB metabolism and secretion. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 106-114
21. Lin Y., Smit M.J., Havinga R., Verkade H.J., Vonk R.J., and Kuipers F. Differential effects of eicosapentaenoic acid on glycerolipid and apolipoprotein B metabolism in primary human hepatocytes compared to HepG2 cells and primary rat hepatocytes. Biochim. Biphys. Acta 1256 (1995) 88-96
22. Zheng X., Avella M., and Botham K.M. Comparison of the effects of dietary n- 3 and n- 6 polyunsaturated fatty acids on very-low-density lipoprotein secretion when delivered to hepatocytes in chylomicron remnants. Biochem. J. 357 (2001) 481-487
23. Horton J.D., Goldstein J.L., and Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109 (2002) 1125-1131
24. Hayhurst G.P., Lee Y.H., Lambert G., Ward J.M., and Gonzalez F.J. Hepatic nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell. Biol. 21 (2001) 1393-1403
25. Petrescu A.D., Hertz R., Bar-Tana J., Schroeder F., and Kier A.B. Ligand specificity and conformational dependence of the hepatic nuclear factor-4α (HNF-4α). J. Biol. Chem. 277 (2002) 23988-23999
26. Pegorier J.-P., Le May C., and Girard J. Control of gene expression by fatty acids. J. Nutr. 134 (2004) 2444S-2449S
27. Jump D.B. Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr. Opin. Lipidol. 13 (2002) 155-164
28. Hertz R., Magenheim J., Berman I., and Bar-Tana J. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α. Nature 392 (1998) 512-516
29. Jump D.B. n- 3 Polyunsaturated fatty acid regulation of hepatic gene transcription. Curr. Opin. Lipidol. 19 (2008) 242-247
30. Ou J., Tu H., Shan B., Luk A., DeBose-Boyd R.A., Bashmakov Y., and Goldstein J.L. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6027-6032
31. Diard P., Malewiak M.-I., Lagrange D., and Griglio S. Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes. Biochem. J. 299 (1994) 889-894
32. Napolitano M., Batt K.V., Avella M., Bravo E., and Botham K.M. Lipid synthesis in macrophages derived from the human cell line THP-1: modulation of the effects of native and oxidized chylomicron-remnant-like particles by oestrogen. Clin. Sci. (Lond) 101 (2001) 403-413
33. Ford R.P., Botham K.M., Suckling K.E., and Boyd G.S. Characterisation of rat hepatocyte monolayers for investigation of the metabolism of bile salts. Biochim. Biophys. Acta 836 (1985) 185-191
34. Isusi E., Aspichueta P., Liza M., Hernandez M.L., Diaz C., Hernandez G., Martinez M.J., and Ochoa B. Short- and long-term effects of atorvastatin, lovastatin and simvastatin on the cellular metabolism of cholesteryl esters and VLDL secretion in rat hepatocytes. Atherosclerosis 153 (2000) 283-294
35. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
36. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
37. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2 (2001) 2002-2007
38. De Pascale C., Avella M., Perona J.S., Ruiz-Gutierrez V., Wheeler-Jones C.P., and Botham K.M. Fatty acid composition of chylomicron remnant-like particles influences their uptake and induction of lipid accumulation in macrophages. FEBS J. 273 (2006) 5632-5640
39. Schultz J.R., Tu H., Luk A., Repa J.J., Medina J.C., Li L., Schwendner S., Wang S., Thoolen M., Mangelsdorf D.J., Lustig K.D., and Shan B. Role of LXRs in control of lipogenesis. Genes Dev. 14 (2000) 2831-2838
40. Rawson R.B. Control of lipid metabolism by regulated intramembrane proteolysis of sterol regulatory element binding proteins (SREBPs). Biochem. Soc. Symp. 70 (2003) 221-231
41. Batt K.V., Avella M., Moore E.H., Jackson B., Suckling K.E., and Botham K.M. Differential effects of low-density lipoprotein and chylomicron remnants on lipid accumulation in human macrophages. Exp. Biol. Med. 229 (2004) 528-537
42. Goulter A.B., Avella M.A., Elliott J., and Botham K.M. Chylomicron remnant-like particles inhibit receptor-mediated endothelium-dependent vasorelaxation in porcine coronary arteries. Clin. Sci. (Lond) 103 (2002) 450-460
43. Redgrave T.G., Ly H.L., Quintao E.C., Ramberg C.F., and Boston R.C. Clearance from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man. Biochem. J. 290 (1993) 843-847
44. Maranhao R.C., Feres M.C., Martins M.T., Mesquita C.H., Toffoletto O., Vinagre C.G., Gianinni S.D., and Pileggi F. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease. Atherosclerosis 126 1996 (1996) 15-25
45. Lambert M.S., Botham K.M., and Mayes P.A. Modification of the fatty acid composition of dietary oils and fats on incorporation into chylomicrons and chylomicron remnants. Brit. J. Nutr. 76 (1996) 435-445
46. Bravo E., Ortu G., Cantafora A., Lambert M.S., Avella M., Mayes P.A., and Botham K.M. Comparison of the hepatic uptake and processing of cholesterol from chylomicrons of different fatty acid composition in the rat in vivo. Biochim. Biophys. Acta 1258 (1995) 328-336
47. Lambert M.S., Botham K.M., and Mayes P.A. Variations in composition of dietary fats affect hepatic uptake and metabolism of chylomicron remnants. Biochem. J. 310 (1995) 845-852
48. Lambert M.S., Avella M.A., Berhane Y., Shervill E., and Botham K.M. The fatty acid composition of chylomicron remnants influences their binding and internalization by isolated hepatocytes. Eur. J. Biochem. 268 (2001) 3983-3992
49. Wang S.-L., Du E., Martin T.D., and Davis R.A. Co-ordinate regulation of lipogenesis, the assembly and secretion of apolipoprotein B-containing lipoproteins by sterol response element binding protein 1. J. Biol. Chem. 272 (1997) 19351-19364
50. Botolin D., Wang Y., Christian B., and Jump D. Docosahexaenoic acid [22:6, n-3] stimulates rat hepatic sterol regulatory element-binding protein-1c (SREBP-1c) degradation by an Erk- and 26S proteasome-dependent pathway. J. Lipid Res. 47 (2006) 181-192
51. Repa J.J., Liang G., Ou J., Bashmakov Y., Lobaccaro J.M., Shimomura I., Shan B., Brown M.S., Goldstein J.L., and Mangelsdorf D.J. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14 (2000) 2819-2830
52. Lopez-Soldado I., Warnaluka S., Li J., Zheng X., Avella M., Bravo E., and Botham K. Dietary fish oil influences the expression of hepatic nuclear factor α and related genes. Biochem. Soc. Trans. (2007) www.biochemsoctrans.org/bst/tocprev/meet2006.htm
53. Bravo E., Napolitano M., Lopez-Soldado I., Valeri M., Botham K.M., and Stefanutti C. Hypercholesterolemia alters the responses of the plasma lipid profile and inflammatory markers to supplementation of the diet with n- 3 polyunsaturated fatty acids from fish oil. Eur. J. Clin. Invest. 36 (2006) 788-795
54. Conde K., Roy S., Freake H.C., Newton R.S., and Fernandez M.L. Atorvastatin and simvastatin have distinct effects on hydroxyl methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig. Lipids 34 (1999) 1327-1332
55. Zheng X., Rivabene R., Cavallari C., Napolitano M., Avella M., Bravo E., and Botham K.M. The effects of chylomicron remnants enriched in n- 3 or n- 6 polyunsaturated fatty acids on the transcription of genes regulating their uptake and metabolism by the liver: influence of cellular oxidative state. Free Rad. Biol. Med. 32 (2002) 1123-1131
56. Egert S., Kannenberg F., Somoza V., Erbersdobler H.F., and Wahrburg U. Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. J. Nutr. 139 (2009) 861-868